drugset / Trial / NCT07712497

Titanium-Prepared Platelet-Rich Fibrin for Extraction Socket Healing

NCT07712497

Completed 30 enrolled Eskisehir Osmangazi University
RandomizedParallel-groupSingle-blindTreatment

Summary

Alveolar ridge preservation after tooth extraction is important for maintaining bone volume and facilitating future implant placement. Titanium-prepared platelet-rich fibrin (T-PRF) is an autologous platelet concentrate that may enhance soft and hard tissue healing through the sustained release of growth factors. However, clinical evidence regarding its effect on socket healing remains limited. The aim of this prospective randomized controlled clinical trial is to evaluate the effect of T-PRF on alveolar socket healing following tooth extraction. Participants requiring tooth extraction and subsequent implant placement are randomly assigned to either a T-PRF group or a spontaneous healing (control) group. Cone-beam computed tomography (CBCT) is used to evaluate socket healing volumetrically. The primary outcome is the percentage of socket fill and residual non-ossified socket volume after 3 months. Secondary outcomes include baseline socket volume and postoperative clinical healing. The findings of this study are expected to provide evidence regarding the effectiveness of T-PRF in enhancing alveolar socket healing and preserving ridge dimensions before implant placement.

Timeline

Start
2023-03-01
Primary completion
2023-12-29
Completion
2023-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Titanium-Prepared Platelet-Rich Fibrin Unknown Other

Indications

No indication recorded.